Research Services Division

Deakin Research

Research Output for Stephen Baker

Note: The 2012, 2013, 2014 publications have not been audited.

Jump to: Publications | Grants and Consultancies | HDR completions

Stephen Baker may be from another institution or only recently joined Deakin University.

Publications

2008 External

Ashton, T. D.*, Baker, Stephen. P.*, Hutchinson, Sally. A.* and Scammells, Peter. J.* (2008) N6-substituted C5′-modified adenosines as A1 adenosine receptor agonists, Bioorganic & medicinal chemistry, vol. 16, no. 4, pp. 1861-1873, Pergamon, Oxford, England [C1.1]
ERA journal ID: 1565 – Scopus EID: 2-s2.0-38949188948
Citation counts: Scopus - 16, Thomson - 14
DRO entry for this publication

2007 External

Ashton, T. D.*, Aumann, Kylee M.*, Baker, Stephen P.*, Schiesser, Carl H.* and Scammells, Peter J.* (2007) Structure–activity relationships of adenosines with heterocyclic N6-substituents, Biorganic & medicinal chemistry letters, vol. 17, no. 24, pp. 6779-6784, Elsevier, Amsterdam, The Netherlands [C1.1]
ERA journal ID: 1566 – Scopus EID: 2-s2.0-35848951833
Citation counts: Scopus - 16, Thomson - 15
DRO entry for this publication

2002 External

Hutchinson, Sally A., Baker, Stephen P.* and Scammells, Peter J. (2002) New 2,N6-Disubstituted adenosines: Potent and selective A1 adenosine receptor agonists, Bioorganic & medicinal chemistry, vol. 10, no. 4, pp. 1115-1122, Pergamon, Oxford, England [C1]
ERA journal ID: 1565 – Scopus EID: 2-s2.0-0036007954
Citation counts: Scopus - 17, Thomson - 16
DRO entry for this publication

2000 External

Baker, S.*, Scammells, P. and Belardinelli, L.* (2000) Differential A1-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT1 MF-2 cells, British Journal of Pharmacology, vol. 0, no. 0, pp. 1156-1164, Macmillan Publishers Ltd, Britain [C1]
ERA journal ID: 14703 – Scopus EID: Not tagged
no DRO entry yet for this publication

Beauglehole, A., Baker, S.* and Scammells, P. (2000) Fluorosulfonyl-Substituted Xanthines as Selective Irreversible Antagonists for the A1-Adenosine Receptor, Journal of Medicinal Chemistry, vol. 0, no. 0, pp. 4973-4980, American Chemical Society, Washington, USA [C1]
ERA journal ID: 15248 – Scopus EID: Not tagged
no DRO entry yet for this publication

1999 External

Hutchinson, S., Baker, S.* and Scammells, P. (1999) Adenosine Receptor Ligands with Oxygenated N6 substitutes, Bioorganic and Medicinal Chemistry Letters, vol. 0, no. 0, pp. 933-936, Pergamon, Oxford UK [C1]
ERA journal ID: 1566 – Scopus EID: Not tagged
no DRO entry yet for this publication

1998 External

Scammells, P., Baker, S.* and Beauglehole, A. (1998) XH-14 Analogues as Adenosine Antagonists, Bioorganic & Medicinal Chemistry, vol. 0, no. 0, pp. 1517-1524, Elsevier Science Ltd, Oxford UK [C1]
ERA journal ID: Not matching ERA journal list
no DRO entry yet for this publication

Wright, D., Scammells, P., Baker, S.* and Stewart, S. (1998) "N6-(5,6-Eposynorbornyl)Adenosine Analogs as A1 Adenosine Agonists", Bioorganic and Medicinal Chemistry Letters, vol. 0, no. 0, pp. 3647-3648, Elsevier Science Ltd, Oxford UK [C1]
ERA journal ID: Not matching ERA journal list
no DRO entry yet for this publication

1996 External

Scammells, P., Baker, S.*, Bellardinelli, L.*, Olsson, R.*, Russell, R. and Wright, D. (1996) "The Synthesis of the Novel Adenosine Agonists, Exo- and Endo- N6-(5,6-Epoxynorborn-2-Yl)Adenosine", Tetrahedron, vol. 0, no. 0, pp. 4735-4744, Elsevier Science Ltd [C1]
ERA journal ID: 1602 – Scopus EID: Not tagged
no DRO entry yet for this publication

Srinivas, M.*, Shryock, J.*, Scammells, P., Ruble, J.*, Baker, S.* and Bellardinelli, L.* (1996) A Novel Irreversible Antagonist of the A1-Adenosine Receptor, Molecular Pharmacology, vol. 0, no. 0, pp. 196-205, Am. Soc. Pharm. & Exp. Ther., USA [C1]
ERA journal ID: 14823 – Scopus EID: Not tagged
no DRO entry yet for this publication

1995 External

Bellardinelli, L.*, Baker, S.*, Dennis, D.*, Milner, P.*, Olsson, R.*, Pfister, J.*, Scammells, P. and Shryock, J.* (1995) "1,3-Dipropyl-8-[2-(5,6-Epoxy)Norbornyl]Xanthine, a Potent, Specific and Selective A1 Adenosine Receptor Antagonist in the Guinea Pig Heart and Brain and in Ddt1mf-2 Cells", The Journal of Pharmacology and Experimental Therapeutics, pp. 1167-1176, The American Society for Pharmacology and Experime, USA [M]
no DRO entry yet for this publication

Grants and Consultancies

No grants and/or consultancies found or audited – the 2014 HERDC financial return has not been completed or loaded as yet.

Higher Degree by Research Completions supervised by Stephen Baker

No completions found or audited.

Legend:
* Not a member of Deakin University at time of output.

DRO to publications collection last synchronised: Monday 28th July 2014 10:04pm

Deakin University acknowledges the traditional land owners of present campus sites.

23rd July 2011